Skip to content
OpenCapital
Get started

Elanco Animal Health Inc. ELAN Increase (Decrease) in Other Operating Assets

Increase (Decrease) in Other Operating Assets at other companies

Zoetis logo
ZoetisZTS
——
Kenvue logo
KenvueKVUE
——

Other financials

Income statement

See full
Revenue$1.4B+14.9%
Gross profit$785.0M+14.8%
Net income$57.0M-14.9%
EPS (diluted)$0.11-15.4%

Balance sheet

See full
Cash & equivalents$428.0M-12.1%
Total debt$4.3B-1.7%
Total equity$6.5B+2.3%
Total assets$13.2B+2.2%

Cash flow

See full
Operating cash flow$13.0M+425%
CapEx$51.0M-21.5%
Free cash flow-$38.0M+44.9%

Valuation

See full
Market cap$12.1B+128%
Enterprise value$15.99B+73.1%
P/S2.5×+1.3×

Profitability

See full
Gross margin55.1%+0.2pp
Net margin-4.9%-13.6pp
FCF margin6.4%-1.4pp

Returns & leverage

See full
Return on equity-3.8%-9.9pp
Debt / equity0.7×0.0×
Current ratio2.2×-0.6×

Where this comes from

Reported directly by Elanco Animal Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.

The official record: Elanco Animal Health Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elanco Animal Health Inc.'s increase (decrease) in other operating assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Elanco Animal Health Inc.'s increase (decrease) in other operating assets?
Elanco Animal Health Inc. (ELAN) reported increase (decrease) in other operating assets of -$5.25M in Q4 2025.
How has Elanco Animal Health Inc.'s increase (decrease) in other operating assets changed year-over-year?
Elanco Animal Health Inc.'s increase (decrease) in other operating assets decreased by 90.9% year-over-year, from -$2.75M to -$5.25M.
What is the long-term trend for Elanco Animal Health Inc.'s increase (decrease) in other operating assets?
Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s increase (decrease) in other operating assets has grown at a -4.3% compound annual growth rate (CAGR), from -$25M to -$21M.